Treatment of Neurocysticercosis in children with Albendazole Should it be 1 or 4 weeks

Comparison of one week versus four weeks Albendazole therapy in single small enhancing CT lesion.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2010/091/000045

Enrollment

120

Registered

2010-03-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with seizures and on CT scan of Head having Single small enhancing lesion

Interventions

Intervention1: Albendazole: 15mg/kg/day for 7 days Control Intervention1: Albendazole: 15 mg/kg/day for 28 days

Eligibility

Inclusion criteria

Inclusion criteria: Children up to 12 years of age with seizures and CECT head having- *Single small <20 mm enhancing wel defined lesion with regullar outline *Edema of surrounding area may or not be present *Presence of contrast enhancement - ring or disc type *No midline shift, no mass effect

Exclusion criteria

Exclusion criteria: *Children with multiple lesions on CT head *Children with neurological deficit *Children with suspected Tuberculosis and Mantoux positive *Children who have already got cysticidal therapy * Unstable and critically ill children

Design outcomes

Primary

Measure	Time frame
Resolution of single small enhancing CT lesionTimepoint: 6 months	—

Secondary

Measure	Time frame
Seizure recurrenceTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDr Neeraj Dhawan

PG Student

prabhpreet_021@yahoo.com01722768246

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026